Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia

Oncology Nursing Forum

Volumn 38, Issue 6, 2011, Pages 661-668

  Best, Janie T ^a   Frith, Karen ^b   Anderson, Faye ^b   Rapp, Carla Gene ^c   Rioux, Lisa ^d   Ciccarello, Christina ^d  

^a QUEENS UNIVERSITY OF CHARLOTTE   (United States)

^b UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER CENTER; DRUG ADMINISTRATION; EVIDENCE BASED MEDICINE; FEMALE; FEVER; HOSPITAL; HUMAN; MALE; MIDDLE AGED; NEOPLASM; NEUTROPENIA; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; FEVER; HOSPITALS, URBAN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; ONCOLOGY SERVICE, HOSPITAL; RETROSPECTIVE STUDIES; SOUTHEASTERN UNITED STATES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80655123339     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/11.ONF.661-668     Document Type: Article

References (33)

1. Baltic, T., Schlosser, E., & Bedell, M.K. (2002). Neutropenic fever: One institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy. Clinical Journal of Oncology Nursing, 6, 337-340. doi:10.1188/02.CJON.337-340
2. Book, L. (2008). Neutropenic fever following chemotherapy in a patient with lymphoma. Oncology Nursing Forum, 35, 885-887. doi:10.1188/08.ONF.885-887
3. Camp-Sorrell, D. (2005). Myelosuppression. In J.K. Itano & K.N. Taoka (Eds.), Core curriculum for oncology nursing (4th ed., pp. 257-274). St. Louis, MO: Elsevier.
4. Coughlan, M., & Healy, C. (2008). Nursing care, education, and support for patients with neutropenia. Nursing Standard, 22(46), 35-41.
5. Craig, M., Cumpston, A.D., Hobbs, G.R., DeVetten, M.P., Sarwari, A.R., & Ericson, S.G. (2007). The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplantation, 39, 477-482. doi:10.1038/sj.bmt.1705591 (Pubitemid 46605206)
6. Crawford, J., Dale, D.C., Kuderer, N.M., Culakova, E., Poniewierski, M.S., & Lyman, G.H. (2008). Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: The results of a prospective nationwide study of oncology practice. Journal of the National Comprehensive Cancer Network, 6, 109-117.
7. Cull, L.F., & Nolan, M.B. (2009). Treating neutropenic fever in the emergency department: Delays may be deadly! Journal of Emergency Medicine, 35, 36-39. doi:1016/j.jen.2007.11.002
8. Donohue, R.B. (2006). Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia. Oncology Nursing Forum, 33, 347-352. doi:10.1188.06.ONF.347-352. (Pubitemid 43672488)
9. Dulaney, P., & Stanley, K.M. (2005). Accomplishing change in treatment strategies. Journal of Addictions Nursing, 16(4), 163-167.
10. Eaton, L.H. & Tipton, J.M. (Eds.). (2009). Putting evidence into practice: Improving oncology patient outcomes. Pittsburgh, PA: Oncology Nursing Society.
11. Glasmacher, A., von Lilienfeld-Toal, M., Schulte, S., Hahn, C., Schmidt-Wolf, I.G., & Prentice, A. (2005). An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clinical Microbiology and Infectious Diseases, 11(Suppl. 5), 17-23. (Pubitemid 41348481)
12. Kannangara, S. (2006). Management of febrile neutropenia. Community Oncology, 3, 585-591. (Pubitemid 44785338)
13. Klastersky, J., Paesmans, M., Rubenstein, E.B., Boyer, M., Elting, L., & Field, R., Talcott, J. (2000). The multinational association for supportive care in cancer risk index. Journal of Clinical Oncology, 18, 3038-3051.
14. Knowles, M.S., Holton, E.F., III, & Swanson, R.A. (2005). The adult learner: The definitive classic in adult education and human resource development (6th ed.). Burlington, MA: Elsevier.
15. Koh, A., & Pizzo, P.A. (2002). Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia. Cancer Investigation, 20, 420-433. (Pubitemid 34496574)
16. Kuderer, N.M., Dale, D.C., Crawford, J., Cosler, L.E., & Lyman, G.H. (2006). Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer, 106, 2258-2266. doi:10.1002/ cncr.21847 (Pubitemid 43673249)
17. Marquis, B.L., & Huston, C.J. (2009). Leadership roles and management functions in nursing: Theory and application (6th ed.). Philadelphia, PA: Wolters Kluwer/Lippincott Williams and Wilkins.
18. Maxwell, C., & Stein, A. (2006). Implementing evidence-based guidelines for preventing chemotherapy-induced neutropenia: From paper to clinical practice. Community Oncology, 3, 530-536. (Pubitemid 44476522)
19. McCallin, A. (2006). Interdisciplinary teamwork: Labeling is not enough. Journal of the Australasian Rehabilitation Nurses' Association, 9(2), 6-9.
20. National Comprehensive Cancer Network. (2011). NCCN Clinical Practice Guidelines in Oncology: Prevention and treatment of cancer-related infections [v.2.2011]. Retrieved from http://www.nccn.org/professionals/physician-gls/pdf/ infections.pdf
21. Natsch, S., Kullberg, B.J., Meis, J.F., & van der Meer, J.W. (2000). Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department. Archives of Internal Medicine, 160, 1317-1320. (Pubitemid 30252778)
22. Nirenberg, A., Bush, A.P., Davis, A., Friese, C.R., Gillespie, T.W., & Rice, R.D. (2006a). Neutropenia: State of the knowledge part 1. Oncology Nursing Forum, 33, 1193-1201. doi:1188/06.ONF.1193-1201
23. Nirenberg, A., Bush, A.P., Davis, A., Friese, C.R., Gillespie, T.W., & Rice, R.D. (2006b). Neutropenia: State of the knowledge part II. Oncology Nursing Forum, 33, 1202-1208. doi:10.1188/06.ONF.1202-1208
24. Nirenberg, A., Mulhearn, L., Lin, S., & Larson, E. (2004). Emergency department waiting times for patients with cancer with febrile neutropenia: A pilot study. Oncology Nursing Forum, 31, 711-715.
25. Perrone, J., Hollander, J.E., & Datner, E.M. (2004). Emergency department evaluation of patients with fever and chemotherapy-induced neutropenia. Journal of Emergency Medicine, 27, 115-119. (Pubitemid 38917192)
26. Rolston, K.V. (2004). The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: Salient features and comments. Clinical Infectious Disease, 39(Suppl. 1), S44-S48. doi:1058-4838/2004/3301S1-0008$15.30 (Pubitemid 38971475)
27. Salter, C. (2005). Clinical pathways in the emergency department: Successful implementation of "adult patients who are febrile following chemotherapy" pathway. Australasian Emergency Nursing Journal, 8, 27-34. doi:10.1016/j.aenj.2005.04.005 (Pubitemid 44360591)
28. Sano, H.S., Waddell, J.A., Solimando, D.A., Doulaveris, P., & Myhand, R. (2005). Study of the effect of standardized chemotherapy order forms on prescribing errors and antiemetic cost. Journal of Oncology Pharmacy Practice, 11, 21-30. doi:10.1191/1078155205jp149oa (Pubitemid 40674354)
29. Simms, E. (2006). The components of change: Creativity and innovation, critical thinking, and planned change. In L. Roussel, R.C. Swansburg, & R.J. Swansburg (Eds.), Management and leadership for nurse administrators (4th ed., pp. 55-71). Boston, MA: Jones and Bartlett.
30. Viscoli, C., Varnier, O., & Machetti, M. (2005). Infections in patients with febrile neutropenia: Epidemiology, microbiology, and risk stratification. Clinical Infectious Diseases, 40(S4), S240-S245. (Pubitemid 40411205)
31. Vogtlander, N.P., Van Kasteren, M.E., Natsch, S., Kullberg, B., Hekster, Y.A., & Van der Meer, J.W. (2004). Improving the process of antibiotic therapy in daily practice: Interventions to optimize timing, dosage adjustment to renal function, and switch therapy. Archives of Internal Medicine, 164, 1206-1212. (Pubitemid 39030357)
32. Wirth, R.A. (2004). Lewin/Schein's change theory. Retrieved from http://www.entarga.com/orgchange/lewinschein.pdf
33. Zuckermann, J., Moreira, L.B., Stoll, P., Moreira, L.M., Kuchenbecker, R.S., & Polanczyk, C.A. (2008). Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Annals of Hematology, 87, 139-145.